Timothy Eugene Sullivan, Chief Financial Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 4,470 shares at $66.81 ($299K) on 2024-01-16, disclosed to the SEC on 2024-01-17.
Open-market sale of $299k APLS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.81 | 2,235 | $149K | 50.0% |
| 2 | $66.81 | 2,235 | $149K | 50.0% |
| Total | $66.81 avg | 4,470 | $299K | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $86K | — | Filing → |
| APLS | SELL | 2025-10-23 | $280K | — | Filing → |
| APLS | SELL | 2025-09-10 | $2.1M | — | Filing → |